American CryoStem Corporation Stock Other OTC
Equities
CRYO
US0253001046
Biotechnology & Medical Research
Financials (USD)
Sales 2020 | 558K | Sales 2021 | 20.59K | Capitalization | 18.15M |
---|---|---|---|---|---|
Net income 2020 | -1M | Net income 2021 | -2M | EV / Sales 2020 | 37 x |
Net Debt 2020 | 911K | Net Debt 2021 | 1.14M | EV / Sales 2021 | 937 x |
P/E ratio 2020 |
-16
x | P/E ratio 2021 |
-6.29
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 44.99% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 61 | 09-03-12 | |
John Arnone
CEO | Chief Executive Officer | 66 | 07-12-31 |
John DiFolco
SAM | Sales & Marketing | 39 | 08-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Arnone
CEO | Chief Executive Officer | 66 | 07-12-31 |
Founder | 61 | 09-03-12 |
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |